Skip to main content
Log in

Routine Lynch screening in EC patients cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2013 euros

  2. microsatellite instability

  3. immunohistochemistry

Reference

  • Goverde A, et al. Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age. Gynecologic Oncology : 24 Oct 2016. Available from: URL: http://doi.org/10.1016/j.ygyno.2016.10.008

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Routine Lynch screening in EC patients cost effective. PharmacoEcon Outcomes News 766, 29 (2016). https://doi.org/10.1007/s40274-016-3550-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3550-y

Navigation